Keyword Search
Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building, CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago, UC= Conference Chicago at University Center
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Dose finding returned 14 record(s)
|
|
Monday, 08/01/2016
|
Design for Dose-Finding Trials (Phase I/II or Post-Marketing Trials)
Lei Nie, FDA
|
Dose Finding for Drug Combination in Early Cancer Phase I Trials using Conditional Continual Reassessment Method
Quanlin Li; Mourad Tighiouart, Cedars-Sinai Medical Center; Marcio Diniz, Cedars-Sinai Medical Center
|
Bayesian Approach for Proof of Concept and Dose-Finding Under Model Uncertainty for Binary Response
Yuanyuan Tang, Saint Luke's Health System; Chunyan Cai, The University of Texas at Houston; Jianghua He, University of Kansas Medical Center; Liangrui Sun
|
A New Design for Drug Combination in Phase I Dose-Finding Clinical Trials
Jim Xiang, Janssen; Grace Liu, Johnson & Johnson; James Pan, Janssen
9:35 AM
|
Personalized Dose Finding Using Outcome Weighted Learning
Guanhua Chen, Vanderbilt University ; Donglin Zeng, The University of North Carolina at Chapel Hill; Michael R. Kosorok, The University of North Carolina at Chapel Hill
10:35 AM
|
Bayesian Approach for Proof of Concept and Dose-Finding Under Model Uncertainty for Binary Response
Yuanyuan Tang, Saint Luke's Health System; Chunyan Cai, The University of Texas at Houston; Jianghua He, University of Kansas Medical Center; Liangrui Sun
11:35 AM
|
A Simple Bayesian Design to Identify Maximum Tolerated Dose Contour for Drug Combination Trials
Liangcai Zhang, Rice University; Ying Yuan, MD Anderson Cancer Center
2:20 PM
|
BOIN: A Simple, Ethical Bayesian Optimal Design for Phase I Oncology Trials
Ying Yuan, MD Anderson Cancer Center; Suyu Liu, MD Anderson Cancer Center
2:25 PM
|
|
|
